We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
429 hedge funds and large institutions have $6.41B invested in Corcept Therapeutics in 2025 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 146 increasing their positions, 156 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
24% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 50
19% more call options, than puts
Call options by funds: $74.4M | Put options by funds: $62.4M
9% more capital invested
Capital invested by funds: $5.87B → $6.41B (+$537M)
2% more funds holding
Funds holding: 422 → 429 (+7)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
6% less repeat investments, than reductions
Existing positions increased: 146 | Existing positions reduced: 156
1.27% less ownership
Funds ownership: 74.52% → 73.25% (-1.3%)
Holders
429
Holders Change
+7
Holders Change %
+1.66%
% of All Funds
5.63%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
62
Increased
146
Reduced
156
Closed
50
Calls
$74.4M
Puts
$62.4M
Net Calls
+$11.9M
Net Calls Change
+$45.2M
Top Buyers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$92.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$61.1M |
| 3 |
JP Morgan Chase
New York
|
+$42.5M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$32.1M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$27.9M |
Top Sellers
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$39.2M |
| 2 |
BlackRock
New York
|
-$34.9M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$32.7M |
| 4 |
Morgan Stanley
New York
|
-$30.9M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$30.4M |
